| NUF2 protein |
146706-20-9 | NUF1 protein |
| NT-3 PRIMER PAIR |
| NTproBNP(1-76) |
| NT1 protein, Plasmodium falciparum |
| NTP Set (100 mM)
|
| NTP Set, solution 100 mM |
| NT-PROBNP,MABANTI- |
| NTPs Set, solution 100 mM |
147995-31-1 | Nt-rab5 protein |
304008-29-5 | N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]methanesulfonamide |
78510-19-7 | N-trans-Feruloyl-3-methoxytyramine |
215803-78-4 | N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide |
| N-TRANS-COUMAROYLOCTOPAMINE |
| N-TRANS-FERULOYLOCTOPAMINE |
| N-trans-2-((2-(acetylamino)cyclohexyl)acetyl)-alanyl-glutamic acid |
1138-15-4 | N-TRANS-CINNAMOYLIMIDAZOLE |
105746-46-1 | N-(TRANS-4-TERT-BUTYL-CYCLOHEXYL)CARBONYL-D-PHENYLALANINE |
| N-(TRANS-4-HYDROXYCYCLOHEXYL)2-NITROBENZYLAMINE HCL |
105746-37-0 | N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine |
56720-98-0 | (+/-) N-TRANS[ETHOXY CARBONMETHYL]-1-PHENYLETHYLAMINE |
| [15N]TRANS-ZEATIN 98 (HPLC) |
66648-43-9 | N-Trans-Feruloyltyramine |
| N-trans-Cinnamoyltyramine |
| N-[TRANS-4-(SUCCINIMIDYLOXYCARBONYL)CYCLOHEXYLMETHYL]-SULFORHODAMINE B-ACID AMIDE |
| N-(trans-3-Hydroxycotinine)-b-D-glucuronidemethyl-D3 |
| N-(trans-3-Hydroxycotinine)-b-D-glucuronide |
6025-53-2 | trans-Zeatin-riboside |
479253-00-4 | N-trans-BOC-(3S)-Fluoropyrrolidine |
2979-51-3 | N-TRANS-CINNAMOYLIMIDAZOLE |
| N-trans-Cinnamoyl-N-phenyl-1-pyrrolidinecarbothioamide |
| N-trans-Cinnamoyl-N-phenyl-4-morpholinecarbothioamide |
| N-trans-Cinnamoyl-N-phenyl-1-piperidinecarbothioamide |
| N-trans-Cinnamoyl-N-phenyl-10H-phenothiazine-10-carbothioamide |
99128-91-3 | NT2 purpurin |
107634-78-6 | NT1 purpurin |
| ntrB protein, Rhizobium |
| ntrC protein, Rhizobium |
| NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2)
|
| NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2) A
|
| NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2, Nerve growth factor-2) |
| NT-4, Recombinant, Human (Neurotrophin 4)
|
| NT-1, Recombinant, Human (Neurotrophin 1/B Cell Stimulating Factor 3, BCSF-3)
|
| NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2) B
|
| NT-4, Recombinant, Human (Neurotrophin 4) A
|
| Nug1 protein |
| n-Triacontane Solution |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-3,4-dihydro-2H-1-benzopyran-4-amine |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclopentanamine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1-azabicyclo[2.2.2]octan-3-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}thiolan-3-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-2,3-dihydro-1H-inden-1-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-3,4-dihydro-2H-1-benzothiopyran-4-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclohexanamine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cycloheptanamine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1,4-dioxaspiro[4.5]decan-8-amine |
| N1-[4-(1,4,5-triazatricyclo[5.2.2.0~2,6~]undec-5-en-3-yl)phenyl]acetamide |
400081-70-1 | N-[1,2,4]triazolo[1,5-a]pyridin-8-ylmethanesulfonamide |
400081-71-2 | N-[1,2,4]triazolo[1,5-a]pyridin-8-ylcyclopropanecarboxamide |
| N-1,2,4-TRIAZIN-3-YLTHIOUREA |
338419-03-7 | N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YLPENTANAMIDE |
638-68-6 | N-TRIACONTANE |
338419-02-6 | N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YL-3-(TRIFLUOROMETHYL)BENZENECARBOXAMIDE |
| N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YL-1,2,3-THIADIAZOLE-4-CARBOXAMIDE |
93952-07-9 | N-TRIACONTANE-D62 |
70851-48-8 | N-TRIACONTYLTRICHLOROSILANE |
338406-04-5 | N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YLBENZENECARBOXAMIDE |
| 1-[N-(1,2,4-TRIAZOL-4-YL)AMINO]-2-(TRIFLUOROACETYL)CYCLOHEX-1-ENE |
| N-1,3,5-TRIAZIN-2-YLTHIOUREA |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclohexanamine |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)thiolan-3-amine |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclooctanamine |
| N-[γ-Trialkoxy(C=12)silylpropyl]-N-(β-aminoethyl)amine |
| N-(γ-Trialkoxysilylpropyl)-N-(N'-alkyl-β-aminoethyl)ammonium[salt alkoxy(C=12),alkyl(C=120),acid residue(Cl,Br,I,CH3COO)] |
| N-([1,2,4]triazolo[1,5-a]pyrimidin-2-ylcarbonyl)glycine |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cycloheptanamine |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)-2,3-dihydro-1H-inden-1-amine |
879055-48-8 | N-(3-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-ylphenyl)-2-thiophenecarboxamide |
| N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)-1-azabicyclo[2.2.2]octan-3-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclooctanamine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1,2,3,4-tetrahydronaphthalen-1-amine |
| N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclopentanamine |
| N-(2,4,6-tribromophenyl)-octahydro-1H-indole-2-carboxamide |
| N-(2,4,6-tribromophenyl)-1,4-dioxaspiro[4.5]decan-8-amine |
| N-(2,4,6-tribromophenyl)piperazine-1-sulfonamide |
| N-(2,4,6-tribromophenyl)-3,4-dihydro-2H-1-benzopyran-4-amine |
| N-(2,4,6-tribromophenyl)piperidine-2-carboxamide |
| N-(2,4,6-tribromophenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine |
| N-[2-(2,4,6-tribromophenoxy)ethyl]cyclopropanamine |
| N-[3-(2,4,6-tribromophenoxy)propyl]cyclopropanamine |
| N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZENE-1-SULFONAMIDE |
| N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZAMIDE |
| N1-[2-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)ETHYL]-4-CHLOROBENZENE-1-SULFONAMIDE |
607-93-2 | N-(2,4,6-tribromophenyl)acetamide |
| N1-[2-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)ETHYL]-4-CHLOROBENZENE-1-SULPHONAMIDE |
| N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZENE-1-SULPHONAMIDE |
72002-23-4 | N-(2,4,6-tribromophenyl)formamide |
51895-55-7 | N-[3-(tributoxysilyl)propyl]ethylenediamine |
| N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]ACETAMIDE |
| N-(TRIBROMOPHOSPHINO)-N,N-DIMETHYL-AMINOMETHYL POLYSTYRENE (16-50 MESH, 1.0-1.5 MMOL/G) |